Drugs / Iodinated Active Charcoal
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01404000 Comparator | Nov 2011 → May 2013 | chronic obstructive pulmonary disease | PharmaLundensis AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodinated Active Charcoal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01404000 ↗ |
| Route | Oral | “3 g will be given as an oral suspension once daily for 56 days” NCT01404000 ↗ |